Changing population characteristics, effect-measure modification, and cancer risk factor identification.

Martha L Slattery, Maureen A Murtaugh, Charles Quesenberry, Bette J Caan, Sandra Edwards, Carol Sweeney
{"title":"Changing population characteristics, effect-measure modification, and cancer risk factor identification.","authors":"Martha L Slattery,&nbsp;Maureen A Murtaugh,&nbsp;Charles Quesenberry,&nbsp;Bette J Caan,&nbsp;Sandra Edwards,&nbsp;Carol Sweeney","doi":"10.1186/1742-5573-4-10","DOIUrl":null,"url":null,"abstract":"<p><p>Epidemiologic studies have identified a number of lifestyle factors, e.g. diet, obesity, and use of certain medications, which affect risk of colon cancer. However, the magnitude and significance of risk factor-disease associations differ among studies. We propose that population trends of changing prevalence of risk factors explains some of the variability between studies when factors that change prevalence also modify the effect of other risk factors. We used data collected from population-based control who were selected as study participants for two time periods, 1991-1994 and 1997-2000, along with data from the literature, to examine changes in the population prevalence of aspirin and non-steroidal anti-inflammatory medication (NSAID) use, obesity, and hormone replacement therapy (HRT) over time. Data from a population-based colon cancer case-control study were used to estimate effect-measurement modification among these factors. Sizeable changes in aspirin use, HRT use, and the proportion of the population that is obese were observed between the 1980s and 2000. Use of NSAIDs interacted with BMI and HRT; HRT use interacted with body mass index (BMI). We estimate that as the prevalence of NSAIDs use changed from 10% to almost 50%, the colon cancer relative risk associated with BMI >30 would change from 1.3 to 1.9 because of the modifying effect of NSAIDs. Similarly, the relative risk estimated for BMI would increase as the prevalence of use of HRT among post-menopausal women increased. In conclusion, as population characteristics change over time, these changes may have an influence on relative risk estimates for colon cancer for other exposures because of effect-measure modification. The impact of population changes on comparability between epidemiologic studies can be kept to a minimum if investigators assess exposure-disease associations within strata of other exposures, and present results in a manner that allows comparisons across studies. Effect-measure modification is an important component of data analysis that should be evaluated to obtain a complete understanding of disease etiology.</p>","PeriodicalId":87082,"journal":{"name":"Epidemiologic perspectives & innovations : EP+I","volume":"4 ","pages":"10"},"PeriodicalIF":0.0000,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1742-5573-4-10","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiologic perspectives & innovations : EP+I","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1742-5573-4-10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

Abstract

Epidemiologic studies have identified a number of lifestyle factors, e.g. diet, obesity, and use of certain medications, which affect risk of colon cancer. However, the magnitude and significance of risk factor-disease associations differ among studies. We propose that population trends of changing prevalence of risk factors explains some of the variability between studies when factors that change prevalence also modify the effect of other risk factors. We used data collected from population-based control who were selected as study participants for two time periods, 1991-1994 and 1997-2000, along with data from the literature, to examine changes in the population prevalence of aspirin and non-steroidal anti-inflammatory medication (NSAID) use, obesity, and hormone replacement therapy (HRT) over time. Data from a population-based colon cancer case-control study were used to estimate effect-measurement modification among these factors. Sizeable changes in aspirin use, HRT use, and the proportion of the population that is obese were observed between the 1980s and 2000. Use of NSAIDs interacted with BMI and HRT; HRT use interacted with body mass index (BMI). We estimate that as the prevalence of NSAIDs use changed from 10% to almost 50%, the colon cancer relative risk associated with BMI >30 would change from 1.3 to 1.9 because of the modifying effect of NSAIDs. Similarly, the relative risk estimated for BMI would increase as the prevalence of use of HRT among post-menopausal women increased. In conclusion, as population characteristics change over time, these changes may have an influence on relative risk estimates for colon cancer for other exposures because of effect-measure modification. The impact of population changes on comparability between epidemiologic studies can be kept to a minimum if investigators assess exposure-disease associations within strata of other exposures, and present results in a manner that allows comparisons across studies. Effect-measure modification is an important component of data analysis that should be evaluated to obtain a complete understanding of disease etiology.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
改变人群特征、效应测量修正和癌症危险因素识别。
流行病学研究已经确定了一些生活方式因素,如饮食、肥胖和某些药物的使用,这些因素会影响患结肠癌的风险。然而,不同研究中危险因素与疾病关联的程度和意义不同。我们提出,当改变流行率的因素也改变其他危险因素的影响时,危险因素流行率变化的人口趋势解释了研究之间的一些可变性。我们使用从1991-1994年和1997-2000年两个时间段的研究参与者中收集的以人群为基础的对照数据,以及文献数据,来检查阿司匹林和非甾体抗炎药(NSAID)使用、肥胖和激素替代疗法(HRT)的人群患病率随时间的变化。一项以人群为基础的结肠癌病例对照研究的数据被用来估计这些因素之间的效应测量修正。在20世纪80年代至2000年间,观察到阿司匹林的使用、激素替代疗法的使用和肥胖人口的比例发生了相当大的变化。使用非甾体抗炎药与BMI和HRT的相互作用;激素替代疗法的使用与身体质量指数(BMI)相互作用。我们估计,随着非甾体抗炎药的使用从10%变化到近50%,由于非甾体抗炎药的调节作用,与BMI >30相关的结肠癌相对风险将从1.3变化到1.9。同样,估计BMI的相对风险会随着绝经后妇女使用HRT的流行率的增加而增加。总之,随着人群特征随时间的变化,这些变化可能会对其他暴露的结肠癌的相对风险估计产生影响,因为效应测量的修改。如果研究人员在其他暴露的层次内评估暴露与疾病的关联,并以允许跨研究比较的方式提出结果,则人口变化对流行病学研究之间可比性的影响可以保持在最低限度。效应测量修正是数据分析的重要组成部分,应该对其进行评估,以获得对疾病病因的完整了解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Extending the sufficient component cause model to describe the Stable Unit Treatment Value Assumption (SUTVA). Use of the integrated health interview series: trends in medical provider utilization (1972-2008). Social network analysis and agent-based modeling in social epidemiology. The use of complete-case and multiple imputation-based analyses in molecular epidemiology studies that assess interaction effects. Attributing the burden of cancer at work: three areas of concern when examining the example of shift-work.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1